Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:44PM ET
62.17
Dollar change
-0.29
Percentage change
-0.46
%
Index- P/E- EPS (ttm)-0.90 Insider Own9.53% Shs Outstand54.60M Perf Week3.19%
Market Cap3.40B Forward P/E20.40 EPS next Y3.05 Insider Trans0.00% Shs Float49.41M Perf Month2.30%
Income-48.78M PEG- EPS next Q0.48 Inst Own106.16% Short Float8.37% Perf Quarter9.80%
Sales1.71B P/S1.99 EPS this Y8.25% Inst Trans-6.07% Short Ratio9.00 Perf Half Y18.58%
Book/sh62.61 P/B0.99 EPS next Y17.32% ROA-1.24% Short Interest4.14M Perf Year23.35%
Cash/sh0.66 P/C93.83 EPS next 5Y9.99% ROE-1.58% 52W Range43.04 - 66.14 Perf YTD10.98%
Dividend Est.- P/FCF265.91 EPS past 5Y- ROI-1.24% 52W High-6.00% Beta1.82
Dividend TTM- Quick Ratio1.16 Sales past 5Y1.85% Gross Margin50.37% 52W Low44.45% ATR (14)1.26
Dividend Ex-Date- Current Ratio2.43 EPS Y/Y TTM-289.10% Oper. Margin-1.85% RSI (14)59.10 Volatility1.63% 2.08%
Employees6550 Debt/Eq0.16 Sales Y/Y TTM-22.79% Profit Margin-2.86% Recom1.27 Target Price76.33
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q107.63% Payout- Rel Volume0.50 Prev Close62.46
Sales Surprise2.20% EPS Surprise6.76% Sales Q/Q11.33% EarningsFeb 22 BMO Avg Volume459.69K Price62.17
SMA202.15% SMA503.03% SMA20010.50% Trades Volume186,076 Change-0.46%
Date Action Analyst Rating Change Price Target Change
Feb-13-24Initiated Stephens Overweight $72
Jan-22-24Initiated UBS Buy $75
Jan-03-24Initiated William Blair Outperform
Dec-15-23Reiterated Needham Buy $62 → $70
Oct-20-23Initiated ROTH MKM Buy $75
Jun-26-23Initiated Needham Buy $70
May-12-23Upgrade Wells Fargo Equal Weight → Overweight $55 → $67
Oct-12-22Initiated Jefferies Buy $60
Oct-11-22Initiated Goldman Buy $57
Sep-12-22Initiated Evercore ISI Outperform $68
Today 07:00AM
Feb-23-24 10:20AM
Feb-22-24 11:06PM
06:31AM
06:23AM
06:00AM Loading…
06:00AM
Feb-12-24 11:30AM
Feb-07-24 04:15PM
Jan-29-24 08:00AM
Jan-26-24 06:00AM
Jan-25-24 08:30AM
Jan-04-24 10:53AM
Jan-03-24 06:00AM
Dec-28-23 05:00AM
Dec-05-23 06:00AM
09:55AM Loading…
Nov-29-23 09:55AM
Nov-16-23 04:15PM
Nov-13-23 09:55AM
Nov-08-23 08:42PM
08:43AM
01:16AM
Nov-07-23 09:51PM
07:15AM
06:50AM
06:12AM
06:00AM
Oct-31-23 10:01AM
Oct-30-23 08:00AM
Oct-25-23 12:10PM
Oct-20-23 06:00AM
06:58AM Loading…
Oct-19-23 06:58AM
06:51AM
Oct-16-23 07:00AM
Sep-29-23 11:34AM
Sep-25-23 06:35AM
06:00AM
05:00AM
Sep-18-23 08:30AM
Sep-07-23 08:40AM
Aug-08-23 08:24AM
Aug-03-23 10:43AM
07:25AM
06:21AM
06:00AM
Jul-21-23 04:34AM
Jul-11-23 04:45PM
Jul-10-23 07:28AM
Jul-06-23 08:30AM
Jul-03-23 04:27AM
Jun-28-23 04:30PM
Jun-14-23 07:21AM
07:06AM
Jun-02-23 04:01PM
May-22-23 08:47AM
May-04-23 07:25AM
06:20AM
06:00AM
May-01-23 05:45PM
Apr-27-23 08:35AM
Apr-13-23 12:21PM
Apr-03-23 07:00AM
Mar-16-23 07:13AM
06:58AM
Mar-15-23 04:30PM
Mar-03-23 10:35AM
Feb-27-23 08:00AM
Feb-24-23 05:20AM
Feb-23-23 06:00AM
Feb-10-23 03:45PM
Feb-08-23 06:00AM
Jan-17-23 09:00AM
Jan-14-23 03:14PM
Jan-12-23 06:08AM
Jan-05-23 03:10PM
Dec-28-22 07:23AM
07:08AM
Dec-12-22 09:03AM
Dec-01-22 09:00AM
Nov-17-22 10:05AM
08:00AM
Nov-11-22 05:39AM
Nov-10-22 10:30AM
Nov-02-22 07:25AM
06:00AM
Oct-28-22 03:58PM
Oct-27-22 10:03AM
Oct-26-22 12:10PM
10:02AM
Oct-13-22 09:30AM
Sep-08-22 09:30AM
Aug-25-22 04:01PM
Aug-05-22 06:16AM
Aug-04-22 06:00AM
Jul-19-22 08:00AM
Jul-12-22 04:01PM
Jul-06-22 08:00AM
Jul-05-22 07:44AM
Jun-30-22 08:00AM
Jun-15-22 06:00AM
Jun-06-22 04:05PM
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KLECKNER JOHNPrincipal Accounting OfficerAug 07 '23Sale59.1817410,2974,218Aug 07 08:00 PM
KLECKNER JOHNPrincipal Accounting OfficerJul 20 '23Sale65.32674,3764,392Jul 20 08:00 PM
BERRY PHILLIP BENJAMIN (BEN)SVP, Chief Financial OfficerJun 02 '23Sale54.1764534,94020,223Jun 02 08:00 PM
Vinnakota RajivDirectorMay 08 '23Option Exercise42.431,39659,23213,297May 09 08:00 PM
Vinnakota RajivDirectorMay 08 '23Sale57.181,39679,82311,901May 09 08:00 PM
Shirley BradyPres. & COOApr 03 '23Sale53.5469537,21061,291Apr 04 04:58 PM